Pathology
Assay for Risk of Kidney-Allograft Rejection Receives CE Marking Approval
European CE marking approval was recently granted for a sensitive, solid-phase assay for the characterization of donor-specific antibodies that distinguish complement binding antibodies from non-complement binding antibodies. More...18 Nov 2013
Gold Member
Collection and Transport System
PurSafe Plus®
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
In Other News
Biomarker Helps Guide Treatment of Melanoma
MicroRNA Deficiency Points to Increased Lung Cancer Risk
Potential Biomarkers Found for Early Alzheimer's Diagnosis
Novel Test Improves Detection of Thyroid Cancer, Reduces Unnecessary Surgeries
New Biomarker Genes Enable Early Detection of Pancreatic Cancer
Fully Automated Gram Stain Launched
Pathologists Collaborate to Improve Reporting and Accessibility of Cancer Pathology Findings
Urinary Biomarkers Link Chronic Kidney Disease to Mitochondrial Dysfunction
Hereditary Cancer Assay Improves Colon Cancer Testing
Protein Identified That May Predict Thyroid Cancer Recurrence
Diagnostic Test Clinically Validated For Breast Cancer Mutations
Biomarkers Help Predict Outcome in Deadly Lung Disease
Macrophage-Derived Mediators Are Urolithiasis Risk Biomarkers
Papillomavirus Linked to Oropharyngeal Cancer in Young Adults
Novel Test Detects Early Prostate Cancer
Early Liver Cancer Diagnosed With Molecular Test
Fragile X Syndrome Protein Linked to Breast Cancer
Gene-Expression Biomarker Predicts Risk of Breast Cancer Recurrence
Molecular Basis of Alzheimer’s Disease Determined
Molecular Test Identifies Indolent Prostate Cancer
Solid Tumor Marker Diagnostic Test Receives CE Certification
Genetic Deletion Linked to Early-Onset Parkinson's Disease
Molecular Method Detects Colon Cancer Earlier
The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.